Health
New target for drug development could fill a major gap in depression treatment – News-Medical.net – Burnie Online News
Vanderbilt researchers found that ketamine’s rapid antidepressant action is due to specific synaptic effects.
THE IDEAVanderbilt researchers found that ketamine’s rapid antidepressant action is due to specific synaptic effects. This represents a new target for drug development that could fill a major gap in care for depression.The research was led by Lisa Monteggia,……
Continue Reading
-
Noosa News19 hours agoBidding for a good cause
-
General22 hours agoRyan Routh to face court charged with attempted assassination of Donald Trump
-
Noosa News18 hours agoData shows 73 serving and former Australian Defence Force members died by suicide in 2023
-
Noosa News17 hours agoAustralian-funded PALM scheme liaison workers say they went months without pay